Role of the arcuate nucleus of the hypothalamus in regulation of body weight during energy deficit

Molecular and Cellular Endocrinology

Volumn 316, Issue 2, 2010, Pages 109-119

  Sainsbury, A ^a,b   Zhang, L ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Appetite; Energy deficit; Hypothalamus; Metabolic rate; Obesity; Physical activity

Indexed keywords

AGOUTI RELATED PROTEIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; DYNORPHIN DERIVATIVE; LEPTIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN;

APPETITE; ARCUATE NUCLEUS; BODY WEIGHT; BRAIN FUNCTION; ENERGY BALANCE; ENERGY CONSERVATION; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD INTAKE; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS FUNCTION; METABOLIC RATE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

AGOUTI-RELATED PROTEIN; ANIMALS; APPETITE; ARCUATE NUCLEUS; BODY WEIGHT; EATING; ENERGY METABOLISM; FASTING; HUMANS; LEPTIN; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEUROPEPTIDE Y; OBESITY; OXYGEN CONSUMPTION; PRO-OPIOMELANOCORTIN; SIGNAL TRANSDUCTION; WEIGHT LOSS;

EID: 72449161077     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.09.025     Document Type: Review

References (168)

1. Abbott C.R., Rossi M., Wren A.M., Murphy K.G., Kennedy A.R., Stanley S.A., Zollner A.N., Morgan D.G., Morgan I., Ghatei M.A., Small C.J., and Bloom S.R. Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology 142 (2001) 3457-3463
2. Ahima R.S., and Flier J.S. Leptin. Annu. Rev. Physiol. 62 (2000) 413-437
3. Ahima R.S., and Lazar M.A. Adipokines and the peripheral and neural control of energy balance. Mol. Endocrinol. 22 (2008) 1023-1031
4. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., and Flier J.S. Role of leptin in the neuroendocrine response to fasting. Nature 382 (1996) 250-252
5. Ahima R.S., Kelly J., Elmquist J.K., and Flier J.S. Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 140 (1999) 4923-4931
6. Asakawa A., Inui A., Yuzuriha H., Nagata T., Kaga T., Ueno N., Fujino M.A., and Kasuga M. Cocaine-amphetamine-regulated transcript influences energy metabolism, anxiety and gastric emptying in mice. Hormone Metabolic Res. 33 (2001) 554-558
7. Bai F.L., Yamano M., Shiotani Y., Emson P.C., Smith A.D., Powell J.F., and Tohyama M. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 331 (1985) 172-175
8. Baran K., Preston E., Wilks D., Cooney G.J., Kraegen E.W., and Sainsbury A. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. Diabetes 51 (2002) 152-158
9. Baranowska B., Wasilewska-Dziubinska E., Radzikowska M., Plonowski A., and Roguski K. Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa. Metabolism 46 (1997) 1384-1389
10. Beck B. Neuropeptides and obesity. Nutrition 16 (2000) 916-923
11. Becker E.E., and Grinker J.A. Meal patterns in the genetically obese Zucker rat. Physiol. Behav. 18 (1977) 685-692
12. Benoit S., Schwartz M., Baskin D., Woods S.C., and Seeley R.J. CNS melanocortin system involvement in the regulation of food intake. Horm. Behav. 37 (2000) 299-305
13. Berman Y., Devi L., Spangler R., Kreek M.J., and Carr K.D. Chronic food restriction and streptozotocin-induced diabetes differentially alter prodynorphin mRNA levels in rat brain regions. Brain Res. Mol. Brain Res. 46 (1997) 25-30
14. Bezaire V., Hofmann W., Kramer J.K., Kozak L.P., and Harper M.E. Effects of fasting on muscle mitochondrial energetics and fatty acid metabolism in Ucp3(-/-) and wild-type mice. Am. J. Physiol. Endocrinol. Metab. 281 (2001) E975-E982
15. Blake N.G., Johnson M.R., Eckland D.J., Foster O.J., and Lightman S.L. Effect of food deprivation and altered thyroid status on the hypothalamic-pituitary-thyroid axis in the rat. J. Endocrinol. 133 (1992) 183-188
16. Boelen A., Kwakkel J., Vos X.G., Wiersinga W.M., and Fliers E. Differential effects of leptin and refeeding on the fasting-induced decrease of pituitary type 2 deiodinase and thyroid hormone receptor beta2 mRNA expression in mice. J. Endocrinol. 190 (2006) 537-544
17. Boelen A., Wiersinga W.M., and Fliers E. Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. Thyroid 18 (2008) 123-129
18. Brady L.S., Smith M.A., Gold P.W., and Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52 (1990) 441-447
19. Bray G.A., and York D.A. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol. Rev. 59 (1979) 719-809
20. Broberger C., Johansen J., Johansson C., Schalling M., and Hokfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15043-15048
21. Brown K.S., Gentry R.M., and Rowland N.E. Central injection in rats of alpha-melanocyte-stimulating hormone analog: effects on food intake and brain Fos. Regul. Pept. 78 (1998) 89-94
22. Butler A.A., and Cone R.D. Knockout models resulting in the development of obesity. Trends Genet. 17 (2001) S50-S54
23. Cameron J.D., Goldfield G.S., Cyr M.J., and Doucet E. The effects of prolonged caloric restriction leading to weight-loss on food hedonics and reinforcement. Physiol. Behav. 94 (2008) 474-480
24. Campfield L.A., Smith F.J., Guisez Y., Devos R., and Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269 (1995) 546-548
25. Cettour-Rose P., and Rohner-Jeanrenaud F. The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology 143 (2002) 2277-2283
26. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., and O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15 (1985) 1159-1181
27. Clement K. Monogenic forms of obesity: from mice to human. Ann. Endocrinol. (Paris) 61 Suppl. 6 (2000) 39-49
28. Cole J.L., Leventhal L., Pasternak G.W., Bowen W.D., and Bodnar R.J. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res. 678 (1995) 168-176
29. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T.L., and Caro J.F. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334 (1996) 292-295
30. Currie P.J., and Coscina D.V. Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus. Peptides 16 (1995) 599-604
31. DeLany J.P., Hansen B.C., Bodkin N.L., Hannah J., and Bray G.A. Long-term calorie restriction reduces energy expenditure in aging monkeys. J. Gerontol. A: Biol. Sci. Med. Sci. 54 (1999) B5-B11 discussion: B12-B13
32. Doucet E., Imbeault P., St-Pierre S., Almeras N., Mauriege P., Richard D., and Tremblay A. Appetite after weight loss by energy restriction and a low-fat diet-exercise follow-up. Int. J. Obes. Relat. Metab. Disord. 24 (2000) 906-914
33. Douyon L., and Schteingart D.E. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocr Metab. Clin. N. Am. 31 (2002) 173-189
34. Dryden S., Pickavance L., Frankish H.M., and Williams G. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res. 690 (1995) 185-188
35. Duan J., Choi Y.H., Hartzell D., Della-Fera M.A., Hamrick M., and Baile C.A. Effects of subcutaneous leptin injections on hypothalamic gene profiles in lean and ob/ob mice. Obesity (Silver Spring) 15 (2007) 2624-2633
36. Duffy P.H., Feuers R.J., Leakey J.A., Nakamura K., Turturro A., and Hart R.W. Effect of chronic caloric restriction on physiological variables related to energy metabolism in the male Fischer 344 rat. Mech. Ageing Dev. 48 (1989) 117-133
37. Duffy P.H., Feuers R., Nakamura K.D., Leakey J., and Hart R.W. Effect of chronic caloric restriction on the synchronization of various physiological measures in old female Fischer 344 rats. Chronobiol. Int. 7 (1990) 113-124
38. Duffy P.H., Feuers R.J., and Hart R.W. Effect of chronic caloric restriction on the circadian regulation of physiological and behavioral variables in old male B6C3F1 mice. Chronobiol. Int. 7 (1990) 291-303
39. Dulloo A.G., and Calokatisa R. Adaptation to low calorie intake in obese mice: contribution of a metabolic component to diminished energy expenditures during and after weight loss. Int. J. Obes. 15 (1991) 7-16
40. Dulloo A.G., and Girardier L. Adaptive changes in energy expenditure during refeeding following low-calorie intake: evidence for a specific metabolic component favoring fat storage. Am. J. Clin. Nutr. 52 (1990) 415-420
41. Dulloo A.G., and Girardier L. 24 hour energy expenditure several months after weight loss in the underfed rat: evidence for a chronic increase in whole-body metabolic efficiency. Int. J. Obes. Relat. Metab. Disord. 17 (1993) 115-123
42. Egawa M., Yoshimatsu H., and Bray G.A. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am. J. Physiol. 260 (1991) R328-R334
43. Erickson J.C., Hollopeter G., and Palmiter R.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274 (1996) 1704-1707
44. Erickson J.C., Clegg K.E., and Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381 (1996) 415-418
45. Evans S.A., Parsons A.D., and Overton J.M. Homeostatic responses to caloric restriction: influence of background metabolic rate. J. Appl. Physiol. 99 (2005) 1336-1342
46. Fekete C., Kelly J., Mihaly E., Sarkar S., Rand W.M., Legradi G., Emerson C.H., and Lechan R.M. Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology 142 (2001) 2606-2613
47. Ferron F., Considine R.V., Peino R., Lado I.G., Dieguez C., and Casanueva F.F. Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa and non-specific eating disorders correlate with the body mass index but are independent of the respective disease. Clin. Endocrinol. (Oxf.) 46 (1997) 289-293
48. Finn P.D., Cunningham M.J., Pau K.Y., Spies H.G., Clifton D.K., and Steiner R.A. The stimulatory effect of leptin on the neuroendocrine reproductive axis of the monkey. Endocrinology 139 (1998) 4652-4662
49. Flier J.S. Clinical review 94: What's in a name? In search of leptin's physiologic role. J. Clin. Endocrinol. Metab. 83 (1998) 1407-1413
50. Frederich R.C., Hamann A., Anderson S., Löllmann B., Lowell B.B., and Flier J.S. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1 (1995) 1311-1314
51. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
52. Gavin L.A., Bui F., McMahon F., and Cavalieri R.R. Sequential deiodination of thyroxine to 3,3′-diiodothyronine via 3,5,3′-triiodothyronine and 3,3′,5′-triiodothyronine in rat liver homogenate. The effects of fasting versus glucose feeding. J. Biol. Chem. 255 (1980) 49-54
53. Gendall K.A., Kaye W.H., Altemus M., McConaha C.W., and La Via M.C. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol. Psychiatry 46 (1999) 292-299
54. Glass M.J., Billington C.J., and Levine A.S. Opioids, food reward, and macronutrient selection. In: Berthoud H.R., and Seeley R.J. (Eds). Neural and Metabolic Control of Macronutrient Intake (2000), CRC Press, New York 407-423
55. Goodrick C.L., Ingram D.K., Reynolds M.A., Freeman J.R., and Cider N.L. Effects of intermittent feeding upon growth, activity, and lifespan in rats allowed voluntary exercise. Exp. Aging Res. 9 (1983) 203-209
56. Goodrick C.L., Ingram D.K., Reynolds M.A., Freeman J.R., and Cider N.L. Differential effects of intermittent feeding and voluntary exercise on body weight and lifespan in adult rats. J. Gerontol. 38 (1983) 36-45
57. Goran M.I. Energy metabolism and obesity. Med. Clin. N. Am. 84 (2000) 347-362
58. Grinspoon S., Gulick T., Askari H., Landt M., Lee K., Anderson E., Ma Z., Vignati L., Bowsher R., Herzog D., and Klibanski A. Serum leptin levels in women with anorexia nervosa. J. Clin. Endocrinol. Metab. 81 (1996) 3861-3863
59. Gutierrez E., Vazquez R., and Boakes R.A. Activity-based anorexia: ambient temperature has been a neglected factor. Psychon. Bull. Rev. 9 (2002) 239-249
60. Hagan M.M., Rushing P.A., Pritchard L.M., Schwartz M.W., Strack A.M., Van Der Ploeg L.H., Woods S.C., and Seeley R.J. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am. J. Physiol. 279 (2000) R47-R52
61. Hahn T.M., Breininger J.F., Baskin D.G., and Schwartz M.W. Coexpression of AGRP and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1 (1998) 271-272
62. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., and Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 (1995) 543-546
63. Hamilton B.S., and Doods H.N. Chronic application of MTII in a rat model of obesity results in sustained weight loss. Obes. Res. 10 (2002) 182-187
64. Hamilton B.S., Paglia D., Kwan A.Y.M., and Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat. Med. 1 (1995) 953-956
65. Hebebrand J., van der Heyden J., Devos R., Kopp W., Herpertz S., Remschmidt H., and Herzog W. Plasma concentrations of obese protein in anorexia nervosa. Lancet 346 (1995) 1624-1625
66. Heilig M., Vecsei L., and Widerlov E. Opposite effects of centrally administered neuropeptide Y (NPY) on locomotor activity of spontaneously hypertensive (SH) and normal rats. Acta Physiol. Scand. 137 (1989) 243-248
67. Herve C., and Fellmann D. Changes in rat melanin-concentrating hormone and dynorphin messenger ribonucleic acids induced by food deprivation. Neuropeptides 31 (1997) 237-242
68. Hukshorn C.J., Menheere P.P., Westerterp-Plantenga M.S., and Saris W.H. The effect of pegylated human recombinant leptin (PEG-OB) on neuroendocrine adaptations to semi-starvation in overweight men. Eur. J. Endocrinol. 148 (2003) 649-655
69. Hukshorn C.J., Westerterp-Plantenga M.S., and Saris W.H. Pegylated human recombinant leptin (PEG-OB) causes additional weight loss in severely energy-restricted, overweight men. Am. J. Clin. Nutr. 77 (2003) 771-776
70. Hwa J.J., Witten M.B., Williams P., Ghibaudi L., Gao J., Salisbury B.G., Mullins D., Hamud F., Strader C.D., and Parker E.M. Activation of the NPYY5 receptor regulates both feeding and energy expenditure. Am. J. Physiol. 277 (1999) R1428-R1434
71. Ingram D.K., Weindruch R., Spangler E.L., Freeman J.R., and Walford R.L. Dietary restriction benefits learning and motor performance of aged mice. J. Gerontol. 42 (1987) 78-81
72. Jarosz P.A., and Metzger B.L. The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating. Biol. Res. Nursing 3 (2002) 198-209
73. Jequier E. Leptin signaling, adiposity, and energy balance. Ann. N. Y. Acad. Sci. 967 (2002) 379-388
74. Jhanwar-Uniyal M., Beck B., Burlet C., and Leibowitz S.F. Diurnal rhythm of neuropeptide Y-like immunoreactivity in the suprachiasmatic, arcuate and paraventricular nuclei and other hypothalamic sites. Brain Res. 536 (1990) 331-334
75. Kalra S.P., Dube M.G., Sahu A., Phelps C.P., and Kalra P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10931-10935
76. Kalra S.P., Dube M.G., Pu S.Y., Xu B., Horvath T.L., and Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20 (1999) 68-100
77. Kask A., Pahkla R., Irs A., Rago L., Wikberg J.E., and Schioth H.B. Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats. Neuroreport 10 (1999) 707-711
78. Kaye W.H., Berrettini W., Gwirtsman H., and George D.T. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch. Gen. Psychiatry 47 (1990) 548-556
79. Kemnitz J.W., Weindruch R., Roecker E.B., Crawford K., Kaufman P.L., and Ershler W.B. Dietary restriction of adult male rhesus monkeys: design, methodology, and preliminary findings from the first year of study. J. Gerontol. 48 (1993) B17-26
80. Kerkerian L., and Pelletier G. Effects of monosodium l-glutamate administration on neuropeptide Y-containing neurons in the rat hypothalamus. Brain Res. 369 (1986) 388-390
81. Keys A., Brozek J., Henschel A., Mickelsen O., and Taylor H.L. The Biology of Human Starvation (1950), University of Minnesota Press, Minneapolis
82. Khawaja X.Z., Green I.C., Thorpe J.R., and Bailey C.J. Increased sensitivity to insulin-releasing and glucoregulatory effects of dynorphin A1-13 and U 50488h in ob/ob versus lean mice. Diabetes 39 (1990) 1289-1297
83. Khawaja X.Z., Chattopadhyay A.K., and Green I.C. Increased beta-endorphin and dynorphin concentrations in discrete hypothalamic regions of genetically obese (ob/ob) mice. Brain Res. 555 (1991) 164-168
84. Kim M.S., Rossi M., Abusnana S., Sunter D., Morgan D.G., Small C.J., Edwards C.M., Heath M.M., Stanley S.A., Seal L.J., Bhatti J.R., Smith D.M., Ghatei M.A., and Bloom S.R. Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes 49 (2000) 177-182
85. Kim M.S., Small C.J., Stanley S.A., Morgan D.G., Seal L.J., Kong W.M., Edwards C.M., Abusnana S., Sunter D., Ghatei M.A., and Bloom S.R. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J. Clin. Invest. 105 (2000) 1005-1011
86. Kimmel H.L., Gong W., Vechia S.D., Hunter R.G., and Kuhar M.J. Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. J. Pharmacol. Exp. Ther. 294 (2000) 784-792
87. Kong W.M., Stanley S., Gardiner J., Abbott C., Murphy K., Seth A., Connoley I., Ghatei M., Stephens D., and Bloom S. A role for arcuate cocaine and amphetamine-regulated transcript in hyperphagia, thermogenesis, and cold adaptation. FASEB J. 17 (2003) 1688-1690
88. Kotz C.M., Briggs J.E., Grace M.K., Levine A.S., and Billington C.J. Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the Rat. Am. J. Physiol. 44 (1998) R471-R477
89. Kowalski T.J., Houpt T.A., Jahng J., Okada N., Liu S.M., Chua Jr. S.C., and Smith G.P. Neuropeptide Y overexpression in the preweanling Zucker (fa/fa) rat. Physiol. Behav. 67 (1999) 521-525
90. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S., Clausen J.T., Jensen P.B., Madsen O.D., Vrang N., Larsen P.J., and Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393 (1998) 72-76
91. Lambert P.D., Wilding J.P., al-Dokhayel A.A., Bohuon C., Comoy E., Gilbey S.G., and Bloom S.R. A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation. Endocrinology 133 (1993) 29-32
92. Larsen P.J., Vrang N., Petersen P.C., and Kristensen P. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats. Obes. Res. 8 (2000) 590-596
93. Larson D.E., Ferraro R.T., Robertson D.S., and Ravussin E. Energy metabolism in weight-stable postobese individuals. Am. J. Clin. Nutr. 62 (1995) 735-739
94. Legradi G., and Lechan R.M. The arcuate nucleus is the major source for neuropeptide Y-innervation of thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology 139 (1998) 3262-3270
95. Legradi G., and Lechan R.M. Agouti-related protein containing nerve terminals innervate thyrotropin- releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology 140 (1999) 3643-3652
96. Legradi G., Emerson C.H., Ahima R.S., Flier J.S., and Lechan R.M. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138 (1997) 2569-2576
97. Legradi G., Emerson C.H., Ahima R.S., Rand W.M., Flier J.S., and Lechan R.M. Arcuate nucleus ablation prevents fasting-induced suppression of ProTRH mRNA in the hypothalamic paraventricular nucleus. Neuroendocrinology 68 (1998) 89-97
98. Leibel R.L., Rosenbaum M., and Hirsch J. Changes in energy expenditure resulting from altered body weight. N. Engl. J. Med. 332 (1995) 621-628
99. Lönnqvist F., Arner P., Nordfors L., and Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat. Med. 1 (1995) 950-952
100. MacLean P.S., Higgins J.A., Johnson G.C., Fleming-Elder B.K., Peters J.C., and Hill J.O. Metabolic adjustments with the development, treatment, and recurrence of obesity in obesity-prone rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R288-R297
101. MacLean P.S., Higgins J.A., Jackman M.R., Johnson G.C., Fleming-Elder B.K., Wyatt H.R., Melanson E.L., and Hill J.O. Peripheral metabolic responses to prolonged weight reduction that promote rapid, efficient regain in obesity-prone rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 (2006) R1577-R1588
102. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P.A., and Friedman J.M. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1 (1995) 1155-1161
103. Makimura H., Mizuno T.M., Roberts J., Silverstein J., Beasley J., and Mobbs C.V. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice. Diabetes 49 (2000) 1917-1923
104. Mantzoros C., Flier J.S., Lesem M.D., Brewerton T.D., and Jimerson D.C. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J. Clin. Endocrinol. Metab. 82 (1997) 1845-1851
105. Mars M., de Graaf C., de Groot L.C., and Kok F.J. Decreases in fasting leptin and insulin concentrations after acute energy restriction and subsequent compensation in food intake. Am. J. Clin. Nutr. 81 (2005) 570-577
106. Marsh D.J., Hollopeter G., Kafer K.E., and Palmiter R.D. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat. Med. 4 (1998) 718-721
107. Martin C.K., Heilbronn L.K., de Jonge L., DeLany J.P., Volaufova J., Anton S.D., Redman L.M., Smith S.R., and Ravussin E. Effect of calorie restriction on resting metabolic rate and spontaneous physical activity. Obesity 15 (2007) 2964-2973
108. Martinez M., Hernanz A., Gomez-Cerezo J., Pena J.M., Vazquez J.J., and Arnalich F. Alterations in plasma and cerebrospinal fluid levels of neuropeptides in idiopathic senile anorexia. Regul. Pept. 49 (1993) 109-117
109. McMinn J.E., Wilkinson C.W., Havel P.J., Woods S.C., and Schwartz M.W. Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000) R695-703
110. Menozzi R., Bondi M., Baldini A., Venneri M.G., Velardo A., and Del Rio G. Resting metabolic rate, fat-free mass and catecholamine excretion during weight loss in female obese patients. Br. J. Nutr. 84 (2000) 515-520
111. Mihaly E., Fekete C., Tatro J.B., Liposits Z., Stopa E.G., and Lechan R.M. Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. J. Clin. Endocrinol. Metab. 85 (2000) 2596-2603
112. Mizuno T.M., and Mobbs C.V. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140 (1999) 814-817
113. Mizuno T.M., Kleopoulos S.P., Bergen H.T., Roberts J.L., Priest C.A., and Mobbs C.V. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47 (1998) 294-297
114. Mizuno T.M., Makimura H., Silverstein J., Roberts J.L., Lopingco T., and Mobbs C.V. Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin. Endocrinology 140 (1999) 4551-4557
115. Moscrip T.D., Ingram D.K., Lane M.A., Roth G.S., and Weed J.L. Locomotor activity in female rhesus monkeys: assessment of age and calorie restriction effects. J. Gerontol. A: Biol. Sci. Med. Sci. 55 (2000) B373-B380
116. Murphy K.G. Dissecting the role of cocaine- and amphetamine-regulated transcript (CART) in the control of appetite. Brief Funct. Genom. Proteom. 4 (2005) 95-111
117. Murphy B., Nunes C.N., Ronan J.J., Hanaway M., Fairhurst A.M., and Mellin T.N. Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. J. Appl. Physiol. 89 (2000) 273-282
118. Nagashima K., Nakai S., Matsue K., Konishi M., Tanaka M., and Kanosue K. Effects of fasting on thermoregulatory processes and the daily oscillations in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003) R1486-R1493
119. Naslund E., Andersson I., Degerblad M., Kogner P., Kral J.G., Rossner S., and Hellstrom P.M. Associations of leptin, insulin resistance and thyroid function with long-term weight loss in dieting obese men. J. Intern. Med. 248 (2000) 299-308
120. Olszanecka-Glinianowicz M., Zahorska-Markiewicz B., Kocelak P., Janowska J., and Semik-Grabarczyk E. The effect of weight reduction on plasma concentrations of ghrelin and insulin-like growth factor 1 in obese women. Endokrynol. Pol. 59 (2008) 301-304
121. Overton J.M., Williams T.D., Chambers J.B., and Rashotte M.E. Cardiovascular and metabolic responses to fasting and thermoneutrality are conserved in obese Zucker rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R1007-R1015
122. Pasman W.J., Saris W.H., and Westerterp-Plantenga M.S. Predictors of weight maintenance. Obes. Res. 7 (1999) 43-50
123. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., and Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269 (1995) 540-543
124. Pesonen U. NPY L7P polymorphism and metabolic diseases. Regul. Pept. 149 (2008) 51-55
125. Pfluger P.T., Kampe J., Castaneda T.R., Vahl T., D'Alessio D.A., Kruthaupt T., Benoit S.C., Cuntz U., Rochlitz H.J., Moehlig M., Pfeiffer A.F., Koebnick C., Weickert M.O., Otto B., Spranger J., and Tschop M.H. Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J. Clin. Endocrin. Metab. 92 (2007) 583-588
126. Ramsey J.J., Roecker E.B., Weindruch R., and Kemnitz J.W. Energy expenditure of adult male rhesus monkeys during the first 30 mo of dietary restriction. Am. J. Physiol. 272 (1997) E901-E907
127. Robinson S.W., Dinulescu D.M., and Cone R.D. Genetic models of obesity and energy balance in the mouse. Annu. Rev. Genet. 34 (2000) 687-745
128. Rohner-Jeanrenaud F. A neuroendocrine reappraisal of the dual-centre hypothesis: its implications for obesity and insulin resistance. Int. J. Obes. 19 (1995) 517-534
129. Rohner-Jeanrenaud F., Craft L.S., Bridwell J., Suter T.M., Tinsley F.C., Smiley D.L., Burkhart D.R., Statnick M.A., Heiman M.L., Ravussin E., and Caro J.F. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats. Int. J. Obes. 26 (2002) 143-149
130. Rosenbaum M., Nicolson M., Hirsch J., Murphy E., Chu F., and Leibel R.L. Effects of weight change on plasma leptin concentrations and energy expenditure. J. Clin. Endocrin. Metab. 82 (1997) 3647-3654
131. Rosenbaum M., Hirsch J., Murphy E., and Leibel R.L. Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function. Am. J. Clin. Nutr. 71 (2000) 1421-1432
132. Sanacora G., Kershaw M., Kinkelstein A.W., and White J.D. Increased hypothalamic content of preproneuropeptide Y mRNA in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127 (1990) 730-737
133. Sandoval D., Cota D., and Seeley R.J. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu. Rev. Physiol. 70 (2008) 513-535
134. Savontaus E., Conwell I.M., and Wardlaw S.L. Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats. Brain Res. 958 (2002) 130-138
135. Schwartz M.W., Marks J.L., Sipols A.J., Baskin D.G., Woods S.C., Kahn S.E., and Porte D.J. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) zucker rats. Endocrinology 128 (1991) 2645-2647
136. Schwartz M.W., Baskin D.G., Bukowski T.R., Kuijper J.L., Foster D., Lasser G., Prunkard D.E., Porte D.J., Woods S.C., Seeley R.J., and Weigle D.S. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45 (1996) 531-535
137. Schwartz M.W., Seeley R.J., Woods S.C., Weigle D.S., Campfield L.A., Burn P., and Baskin D.G. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46 (1997) 2119-2123
138. Shimabukuro M., Koyama K., Chen G., Wang M.Y., Trieu F., Lee Y., Newgard C.B., and Unger R.H. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4637-4641
139. Shizgal P., Fulton S., and Woodside B. Brain reward circuitry and the regulation of energy balance. Int. J. Obes. Relat. Metab. Disord. 25 Suppl. 5 (2001) S17-S21
140. Shutter J.R., Graham M., Kinsey A.C., Scully S., Luthy R., and Stark K.L. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11 (1997) 593-602
141. Small C.J., Kim M.S., Stanley S.A., Mitchell J.R.D., Murphy K., Morgan D.G.A., Ghatei M.A., and Bloom S.R. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes 50 (2001) 248-254
142. Smith K.L., Gardiner J.V., Ward H.L., Kong W.M., Murphy K.G., Martin N.M., Ghatei M.A., and Bloom S.R. Overexpression of CART in the PVN increases food intake and weight gain in rats. Obesity (Silver Spring) 16 (2008) 2239-2244
143. Spiegelman B.M., and Flier J.S. Adipogenesis and obesity: rounding out the big picture. Cell 87 (1996) 377-389
144. Stanley B.G., Kyrkouli S.E., Lampert S., and Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7 (1986) 1189-1192
145. Ste Marie L., Miura G.I., Marsh D.J., Yagaloff K., and Palmiter R.D. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 12339-12344
146. Stricker-Krongrad A., Kozak R., Burlet C., Nicolas J.P., and Beck B. Physiological regulation of hypothalamic neuropeptide Y release in lean and obese rats. Am. J. Physiol. 273 (1997) R2112-R2116
147. Swart I., Jahng J.W., Overton J.M., and Houpt T.A. Hypothalamic NPY, AGRP, and POMC mRNA responses to leptin and refeeding in mice. Am. J. Physiol. 283 (2002) R1020-R1026
148. Sweeney M.E., Hill J.O., Heller P.A., Baney R., and DiGirolamo M. Severe vs moderate energy restriction with and without exercise in the treatment of obesity: efficiency of weight loss. Am. J. Clin. Nutr. 57 (1993) 127-134
149. Szreder Z., Hori T., and Kaizuka Y. Thermoregulatory effect of intracerebral injections of neuropeptide Y in rats at different environmental temperatures. Gen. Pharmacol. 25 (1994) 85-91
150. Thiele T.E., van Dijk G., Yagaloff K.A., Fisher S.L., Schwartz M., Burn P., and Seeley R.J. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am. J. Physiol. 274 (1998) R248-R254
151. Thornton J.E., Cheung C.C., Clifton D.K., and Steiner R.A. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138 (1997) 5063-5066
152. Van Heek M., Compton D.S., France C.F., Tedesco R.P., Fawzi A.B., Graziano M.P., Sybertz E.J., Strader C.D., and Davis H.R. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J. Clin. Invest. 99 (1997) 385-390
153. Vrang N., Larsen P.J., Clausen J.T., and Kristensen P. Neurochemical characterization of hypothalamic cocaine-amphetamine-regulated transcript neurons. J. Neurosci. 19 (1999) RC5
154. Wadden T.A., Mason G., Foster G.D., Stunkard A.J., and Prange A.J. Effects of a very low calorie diet on weight, thyroid hormones and mood. Int. J. Obes. 14 (1990) 249-258
155. Wang C., Billington C.J., Levine A.S., and Kotz C.M. Effect of CART in the hypothalamic paraventricular nucleus on feeding and uncoupling protein gene expression. Neuroreport 11 (2000) 3251-3255
156. Weed J.L., Lane M.A., Roth G.S., Speer D.L., and Ingram D.K. Activity measures in rhesus monkeys on long-term calorie restriction. Physiol. Behav. 62 (1997) 97-103
157. Weinsier R.L., Hunter G.R., Zuckerman P.A., Redden D.T., Darnell B.E., Larson D.E., Newcomer B.R., and Goran M.I. Energy expenditure and free-living physical activity in black and white women: comparison before and after weight loss. Am. J. Clin. Nutr. 71 (2000) 1138-1146
158. Weinsier R.L., Nagy T.R., Hunter G.R., Darnell B.E., Hensrud D.D., and Weiss H.L. Do adaptive changes in metabolic rate favor weight regain in weight-reduced individuals? An examination of the set-point theory. Am. J. Clin. Nutr. 72 (2000) 1088-1094
159. Weinsier R., Hunter G., and Schutz Y. Metabolic response to weight loss. Am. J. Clin. Nutr. 73 (2001) 655-658
160. Westerterp-Plantenga M.S., Saris W.H., Hukshorn C.J., and Campfield L.A. Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men. Am. J. Clin. Nutr. 74 (2001) 426-434
161. Westerterp-Plantenga M.S., Lejeune M.P., Nijs I., van Ooijen M., and Kovacs E.M. High protein intake sustains weight maintenance after body weight loss in humans. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 57-64
162. Wilding J.P.H., Gilbey S.G., Bailey C.J., Batt R.A.L., Williams G., Ghatei M.A., and Bloom S.R. Increased neuropeptide-Y messenger and decreased neurotensin messenger RNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132 (1993) 1939-1944
163. Williams T.D., Chambers J.B., May O.L., Henderson R.P., Rashotte M.E., and Overton J.M. Concurrent reductions in blood pressure and metabolic rate during fasting in the unrestrained SHR. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278 (2000) R255-R262
164. Yu B.P., Masoro E.J., and McMahan C.A. Nutritional influences on aging of Fischer 344 rats: I. Physical, metabolic, and longevity characteristics. J. Gerontol. 40 (1985) 657-670
165. Yu W.H., Kimura M., Walczewska A., Karanth S., and McCann S.M. Role of leptin in hypothalamic-pituitary function. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 1023-1028
166. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., and Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133 (1993) 1753-1758
167. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
168. Ziotopoulou M., Erani D.M., Hileman S.M., Bjorbaek C., and Mantzoros C.S. Unlike leptin, ciliary neurotrophic factor does not reverse the starvation-induced changes of serum corticosterone and hypothalamic neuropeptide levels but induces expression of hypothalamic inhibitors of leptin signaling. Diabetes 49 (2000) 1890-1896